CD24 and pancreatic neoplasm: Because CD133+ and CD24+CD44+ESA+ cells have been documented to be pancreatic cancer stem cells [24], [25], [26], we determined the effect of low concentrations of metformin on these subpopulations, demonstrating a decreased proportion of CD133+ cells.